From discovery to implementation

Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
Journal Impact Factor (JIF 2025) – 2.5
Journal Citation Indicator (JCI 2025) – 0.40
Scopus CiteScore (2025) – 4.2
Index Copernicus Value (ICV 2024) – 161.00
MNiSW – 70 pts
ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

Ahead of print

doi: 10.17219/acem/230917

Publication type: original article

Thematic category: Emergency medicine; evidence-based healthcare

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Lipska E, Mikrut M, Pawlak A. Prospective analysis of medical conditions and interventions among athlete and non-athlete groups at 2 major international multi-sport tournaments [published online as ahead of print on October 20, 2026]. Adv Clin Exp Med. 2026. doi:10.17219/acem/230917

Prospective analysis of medical conditions and interventions among athlete and non-athlete groups at 2 major international multi-sport tournaments

Elżbieta Lipska1,A,B,C,D,F, Marzena Mikrut2,B,E,F, Agata Pawlak3,B,E,F

1 Institute of Mother and Child, Warsaw, Poland

2 Outpatient Clinic, University Clinical Hospital in Wrocław, Poland

3 Polish Medical Air Rescue, Warsaw, Poland

Graphical abstract


Graphical abstracts

Highlights


• Athletes had substantially higher rates of medical interventions and hospital transports than non-athletes during international multi-sport tournaments.
• Injury-related medical interventions and hospital transports were markedly more frequent among athletes than non-athletes.
• Mild medical conditions predominated, while athletes experienced proportionally more injury-related conditions and non-athletes more illness-related conditions.
• Muaythai, American football, BMX freestyle cycling, sumo, and beach handball showed the highest hospital transport rates among athletes.
• Combined athlete and non-athlete medical surveillance supports evidence-based venue medical planning and resource allocation at major sporting events.

Abstract

Background. Medical preparedness for major international multi-sport tournaments requires effective planning of venue medical services for athlete and non-athlete populations. Understanding differences in medical intervention patterns is essential for resource allocation.

Objectives. To compare on-site medical interventions, hospital transports, and related medical conditions managed by venue medical teams (VMTs) between athlete and non-athlete populations during 2 international multi-sport tournaments, and to identify sport disciplines associated with higher hospital transport rates among athletes.

Materials and methods. Prospective data from the World Games 2017 and the European Games 2023, both held in Poland, were analyzed. The study included 9,672 athletes and 355,215 non-athletes. Interventions were classified as on-site medical interventions and hospital transports. Medical conditions were classified as injuries or illnesses and as mild or severe. Incidence rates per 1,000 participant-days and event rates per 100 participants were calculated.

Results. A total of 1,021 medical interventions and 114 hospital transports were recorded. Compared with non-athletes, athletes demonstrated substantially higher incidence rates across all analyzed outcomes. The pooled incidence rate ratio (IRR) was 5.88 (95% confidence interval (95% CI): 5.19–6.65) for total medical interventions and 16.69 (95% CI: 11.24–24.77) for hospital transports, with the largest between-group differences observed for injury-related medical interventions (IRR = 10.87, 95% CI: 8.76–13.49) and injury-related hospital transports (IRR = 24.44, 95% CI: 15.30–39.05). Mild conditions predominated in both groups, whereas injury-related conditions accounted for a greater proportion of medical interventions among athletes and illness-related conditions among non-athletes. Hospital transports were uncommon in both groups but occurred substantially more frequently among athletes and were predominantly injury-related. Muaythai, American football, BMX freestyle cycling, sumo, and beach handball had the highest hospital transport rates.

Conclusions. Athletes and non-athletes demonstrated distinct patterns of medical interventions and related medical conditions during major international multi-sport tournaments. Combined surveillance of both populations provides a comprehensive assessment of VMT workload and supports evidence-based medical planning for future tournaments.

Key words: mass gathering medicine, hospital transport, major sporting tournament, on-site medical intervention

Background

Medical preparedness for major sport tournaments (MSTs) is designed to ensure the health and safety of all participants.1, 2, 3, 4 Effective medical planning requires an integrated model, considering all groups involved – participating athletes and non-athletes, including spectators, technical staff, and volunteers.5, 6, 7, 8, 9, 10 Unique challenges at multi-sport MSTs include dispersed venues, tight competition schedules, diverse sport disciplines, high participant mobility, and constrained medical resources.6, 7, 9, 10 Comprehensive risk analyses therefore incorporate tournament- and venue-specific characteristics, emergency medical system (EMS) and healthcare system capacities, public health, and crisis management.7, 8, 9, 10 Medical data from previous tournaments support precise venue planning.1, 8, 9, 10, 11 Athlete-specific surveillance data on injuries and illnesses have been analyzed across the most prominent tournaments worldwide.12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23 The recently published meta-analysis of 27 articles showed that the overall incidences of injuries and illnesses during the Olympic Games (OG) were 6.50 (95% confidence interval (95% CI): 5.91–7.15) and 3.62 (95% CI: 2.83–4.65), respectively.12 The highest incidences of injuries were observed in taekwondo, football, boxing, handball, and weightlifting. Lower limb injuries had the highest incidence among injury-related medical conditions.12 For non-athlete groups, evidence from prior MSTs demonstrates low rates of on-site medical interventions, mostly related to weather conditions, with only modest increases in emergency department workload.18, 19, 20, 21, 22, 23, 24 The majority of medical conditions have been mild and managed on-site, with only a small proportion requiring hospital transport.17, 18, 19, 20, 21, 22, 23, 24

Despite the growing number of international multi-sport MSTs, comparative analyses evaluating medical service utilization across different types of multi-sport events remain scarce. Poland hosted 2 MSTs within a 6-year period: the World Games (WG) 2017 and the European Games (EG) 2023. Both tournaments were held in similar geographical, environmental, and healthcare policy conditions, with comparable medical reporting systems. This unique setting provides an opportunity to compare patterns of medical service utilization among athletes and non-athletes across different multi-sport MSTs.

Objectives

The primary objective was to analyze whether distinct patterns existed in medical interventions and hospital transport requirements managed by the venue medical teams (VMTs) among athlete and non-athlete populations during 2 international multi-sport MSTs. The study sought to compare their incidence rates (IRs) and patterns between athlete and non-athlete populations and between tournaments. The secondary objective – within the athlete cohort – was to identify sport disciplines associated with a higher frequency of hospital transports and to determine related medical conditions.

Materials and methods

World Games 2017 was a global tournament featuring non-Olympic disciplines. A total of 3,292 athletes competed in 26 indoor and outdoor venues over 11 days. Table 1 lists the disciplines and participants. The tournament was supported by 7,306 staff and volunteers and attracted an estimated 163,324 spectators, based on ticket distribution records. The local organizing committee distributed tickets, ensuring a primarily local audience. The host country provided medical services for all participants. The medical team included 480 medical staff, up to 40 ambulances per day, and 4 referral hospitals. No team physicians were officially registered.

European Games 2023 was a European tournament comprising 10 non-Olympic and 19 Olympic disciplines. A total of 6,380 athletes competed in 26 indoor and outdoor venues over 12 days. Table 2 lists the disciplines and participants. The event was supported by approx. 5,000 staff and 8,000 volunteers and attracted an estimated 171,585 spectators, primarily from the local area. Because of dispersed tournament locations, local medical staff included several hundred professionals from 5 medical service providers, with 7 local medical coordinators, 11 referral hospitals, and 5 ambulatory care units. Lifeguard and mountain rescue teams were additionally deployed for water and mountain sports. National team physicians provided medical support for athletes, and local medical services provided support and transport to hospitals.

A standardized medical reporting system, tailored to the tournament settings, was implemented for both tournaments. Medical coordinators recorded anonymized medical data from VMTs daily and aggregated it into reports. Figure 1 shows an example of the daily report form. Data from team physicians were included only when local medical support was requested, including all hospital transports. Surveillance was based on the standardized metrics, including on-site medical interventions and hospital transports.25, 26, 27

Medical conditions were grouped into injuries and illnesses, mild and severe. The definitions of the International Olympic Committee (IOC) were adopted: an injury is tissue damage or other disarrangement of normal physical function due to participation in sports (for athletes) or tournament activities (for non-athletes), resulting from rapid or repetitive transfer of kinetic energy; an illness is a complaint or disorder not related to injury. Severe conditions were those resulting in prolonged absence from participation or requiring hospital transport, whereas mild conditions did not significantly restrict health.27 A statement was obtained from the Bioethics Committee at the Institute of Mother and Child in Warsaw (Poland), confirming that this analysis did not require individual consent.

The analyzed outcomes included on-site medical interventions and hospital transports related to injuries and illnesses recorded during the analyzed MSTs in both athlete and non-athlete groups. The primary outcomes were total medical interventions and total hospital transports provided by the VMTs. Secondary outcomes included injuries and illnesses, and mild and severe medical conditions. Secondary analyses were considered exploratory and interpreted primarily on the basis of incidence rate ratios (IRRs) and corresponding 95% CIs.

Outcome measures included incidence rates per 1,000 participant-days and event rates per 100 participants, each with 95% CIs. Participant-days were calculated as the total days of exposure contributed by all participants. For athletes, participant-days were estimated by multiplying the number of athletes in each discipline by the number of official competition days. For staff members and volunteers, participant-days corresponded to their working days, whereas spectator exposure was estimated from distributed single-day tickets, with each ticket representing 1 spectator-day. Event rates were compared using Poisson regression models with the logarithm of participant-days included as an offset. Incidence rate ratios with 95% CIs were estimated from model coefficients. Athletes and non-athletes were compared using pooled data from both tournaments, while tournaments were compared separately for athletes and non-athletes.

Because only 2 tournaments were available, clustering at the tournament level could not be evaluated reliably; therefore, tournaments were compared directly using Poisson IRRs. Sparse event counts, particularly illness-related hospital transports, were interpreted cautiously, and exact Poisson methods were considered where appropriate. Statistical inference was based primarily on effect estimates and 95% CIs. Associations were considered statistically significant when the 95% CI did not include 1.0. All analyses were performed in Microsoft Excel 2021 Professional Plus (Microsoft Corp., Redmond, USA), with additional validation in R v. 4.5.0 (R Foundation for Statistical Computing, Vienna, Austria).

The analysis was based on complete surveillance data and did not involve sampling of participants or medical events. Nevertheless, medical events were considered realizations of underlying stochastic processes. Incidence measures, 95% CIs, and IRRs were therefore calculated to quantify variability and enable standardized comparisons between tournaments and participant groups. These measures are not intended to support inference to the general population of athletes or non-athletes but to characterize uncertainty in event occurrence and observed differences.

Results

The cohort comprised nearly 365,000 participants – 9,672 athletes and 355,215 non-athletes. A total of 1,021 medical interventions and 114 hospital transports were reported. Table 3 presents the distribution of medical condition categories among medical interventions and hospital transports by group and tournament. There were 116 venue reports and 15 daily reports at WG 2017, and 134 venue reports and 16 daily reports at EG 2023, including pre-tournament days. The tournaments were not associated with any mass-casualty incidents, major public health threats, or fatalities.

Medical interventions and conditions in athletes

The athlete group reported 442 medical interventions and 78 hospital transports (46,127 participant-days). The pooled incidence rates for medical interventions and hospital transports were 9.58 (95% CI: 8.73–10.50) and 1.69 (95% CI: 1.36–2.09) per 1,000 participant-days, respectively. Injuries were related to 199 medical interventions and 73 hospital transports. The pooled injury incidence rate was 5.90 (95% CI: 5.24–6.62). The incidence rates for injury-related medical interventions and hospital transports were 4.31 (95% CI: 3.76–4.93) and 1.58 (95% CI: 1.26–1.97), respectively. Illnesses required 243 medical interventions and 5 hospital transports. The pooled illness incidence rate was 5.38 (95% CI: 4.75–6.07). The incidence rates for illness-related medical interventions and hospital transports were 5.27 (95% CI: 4.65–5.95) and 0.11 (95% CI: 0.05–0.22), respectively. Mild medical conditions accounted for 338 medical interventions and hospital transports, with a pooled incidence rate of 7.33 (95% CI: 6.59–8.13), whereas severe medical conditions accounted for 182 medical interventions and hospital transports, with an incidence rate of 3.95 (95% CI: 3.41–4.54).

Data on total medical interventions and medical conditions for WG 2017, EG 2023, and the pooled cohort are presented in Table 4, Table 5, Table 6.

Medical interventions and conditions in non-athletes

The non-athlete group reported 579 medical interventions and 36 hospital transports (355,215 participant-days). The pooled incidence rates for medical interventions and hospital transports were 1.63 (95% CI: 1.50–1.77) and 0.10 (95% CI: 0.07–0.14), respectively. Injuries were related to 141 medical interventions and 23 hospital transports. The pooled injury incidence rate was 0.46 (95% CI: 0.40–0.53). The incidence rates for injury-related medical interventions and hospital transports were 0.40 (95% CI: 0.34–0.47) and 0.06 (95% CI: 0.04–0.09), respectively. Illnesses required 438 medical interventions and 13 hospital transports. The pooled illness incidence rate was 1.27 (95% CI: 1.16–1.39). The incidence rates for illness-related medical interventions and hospital transports were 1.23 (95% CI: 1.12–1.35) and 0.04 (95% CI: 0.02–0.06), respectively. Mild medical conditions accounted for 460 medical interventions and hospital transports, with a pooled incidence rate of 1.29 (95% CI: 1.18–1.42), whereas severe medical conditions accounted for 155, with an incidence rate of 0.44 (95% CI: 0.37–0.51).

Athlete and non-athlete groups comparison

Compared with non-athletes, athletes demonstrated consistently higher incidence rates across all analyzed outcomes. In the pooled cohort, the IRR for total medical interventions was 5.88 (95% CI: 5.19–6.65), for injury-related medical interventions 10.87 (95% CI: 8.76–13.49), and for illness-related medical interventions 4.27 (95% CI: 3.65–5.00). Hospital transport rates were substantially higher among athletes. The pooled IRR for total hospital transports was 16.69 (95% CI: 11.24–24.77), 24.44 for injury-related hospital transports (95% CI: 15.30–39.05), and 2.96 for illness-related hospital transports (95% CI: 1.06–8.31). The latter estimate should be interpreted cautiously because of sparse event counts. Athletes also had a higher incidence of both mild and severe medical conditions, with pooled IRRs of 5.66 (95% CI: 4.92–6.51) and 9.04 (95% CI: 7.30–11.20), respectively. The observed differences were not limited to overall event rates but also reflected distinct patterns of medical conditions. Injury-related events accounted for a larger proportion of medical interventions among athletes, whereas illness-related events represented a relatively greater proportion among non-athletes.

Across tournaments, the total population demonstrated higher overall medical intervention rates during WG 2017 compared with EG 2023 (IRR = 1.26, 95% CI: 1.12–1.43), injury-related medical interventions (IRR = 1.72, 95% CI: 1.38–2.13), and severe medical conditions (IRR = 1.46, 95% CI: 1.18–1.81), whereas hospital transport rates remained comparable between tournaments. Among athletes, most medical outcomes occurred at significantly higher rates during WG 2017 than during EG 2023. In contrast, among non-athletes, most between-tournament differences were small and not statistically significant, except for severe medical conditions (IRR = 1.71, 95% CI: 1.24–2.37) and injury-related medical interventions (IRR = 1.91, 95% CI: 1.35–2.69).

Table 7 summarizes the comparative analyses of WG 2017, EG 2023, and the pooled cohort. Table 4, Table 5, Table 6 present descriptive incidence estimates with 95% CIs.

Sport discipline-specific hospital transports and related medical conditions

Among the disciplines, the highest incidence of hospital transports was observed in muaythai – 28.41 (95% CI: 9.22–66.30) and American football – 27.78 (95% CI: 13.32–51.08) at WG 2017; BMX freestyle cycling – 21.28 (95% CI: 2.58–76.86) at EG 2023; sumo – 15.79 (95% CI: 3.26–46.14) and beach handball – 13.47 (95% CI: 6.16–25.58) at WG 2017; taekwondo – 6.05 (95% CI: 2.22–13.16) and rugby sevens 5.36 (95% CI: 1.74–12.51) at EG 2023. Figure 2, Figure 3 present tournament data. These disciplines accounted for 40 of 78 hospital transports (51.3%). In the pooled athlete cohort, hospital transports were predominantly injury-related (93.6%). The highest IRs were reported for upper limb (0.50, 95% CI: 0.32–0.74), head (IR = 0.41, 95% CI: 0.25–0.64), and lower limb injuries (IR = 0.39, 95% CI: 0.23–0.62). Figure 4, Figure 5 present tournament data.

Discussion

This study analyzed patterns of medical interventions and conditions managed by the VMTs in athlete and non-athlete populations during 2 major international multi-sport tournaments held in Poland – the WG 2017 and the EG 2023. The primary outcomes were incidence rates of medical interventions and hospital transports; secondary analyses examined clinical characteristics and the severity of medical conditions to determine patterns of medical demand across participant groups.

Patterns of medical demands

Overall, both tournaments demonstrated a low incidence of medical interventions, ranging from 2.27 to 2.87 per 1,000 participant-days, with the hospital transport incidence approx. nine-to-tenfold lower (0.28 per 1,000 participant-days). Mild medical conditions predominated in all analyzed groups. Among participants requiring hospital transports, injury-related conditions predominated, with incidence rates fivefold higher than those for illnesses. These findings underscored the important role of VMTs in managing most medical interventions on-site, limiting the need for hospital transport and EMS utilization. Hospital transports were primarily required for severe and injury-related conditions. This pattern is further supported by the predominance of illnesses over injuries (IR 1.74 vs 1.09 per 1,000 participant-days) and mild over severe medical conditions (IR 1.99 vs 0.84). However, these results should be interpreted with caution, given the estimation approach used for the spectator group and the reliance on VMTs as the sole data source for athletes.

The athletes

In the athlete group, 5.4% of individuals required medical interventions or hospital transports from VMTs. The overall pattern of medical events in this group differed from that observed in the total cohort. Hospital transports occurred over fivefold less frequently than on-site medical interventions. Mild medical conditions continued to predominate by approximately twofold. Notably, injury and illness incidences were comparable. As expected, injury-related conditions predominated among hospital transports in this group and across all recorded hospital transports.

The incidence of injuries in the analyzed tournaments (IR = 4.31, 95% CI: 3.76–4.93) was lower than the benchmarks reported for the summer OGs: 6.01 (95% CI: 5.65–6.38) in Beijing 2008,12, 13 7.58 (95% CI: 7.18–7.99) in London 2012,12, 14 5.74 (95% CI: 5.41–6.09) in Rio de Janeiro 2016,12, 15 and 5.38 (95% CI: 5.06–5.72) in Tokyo 2020.12, 16 The summer Youth Olympic Games (YOG) in Buenos Aires 2018 demonstrated an even higher injury incidence of 11.95 (95% CI: 11.03–12.93).12, 17 The results observed in this study were closer to those reported for the 2021 Summer World University Games (WUG), which involved 6,500 athletes and reported an injury incidence of 4.9 (95% CI: 4.3–5.4).18

The observed illness incidence (IR = 5.27, 95% CI: 4.65–5.95) was higher than that reported for the OG: 4.22 (95% CI: 3.92–4.53) in 2012,12, 14 3.20 (95% CI: 2.95–3.46) in 2016,12, 15 and 2.28 (95% CI: 2.07–2.50) in 2020,12, 16 as well as for WUG 2021 (2.5, 95% CI: 2.1–2.9).18 YOG 2018 demonstrated a higher illness incidence of 6.45 (95% CI: 5.78–7.18).17 These differences may reflect variations in event scale, competitive demands, and reporting systems. During the OG, medical reporting relied primarily on team physicians, whereas in other MSTs, reporting relied on data collected by VMTs.

The lower incidence of venue medical interventions observed during EG 2023 may also reflect differences in medical service organization. At WG 2017, VMTs handled most athlete medical care, whereas at EG 2023, team physicians managed a substantial part of the medical workload. This difference in data-collection procedures may have led to underreporting of mild medical conditions.

The non-athletes

The profile of medical interventions in the non-athlete group differed from that observed in athletes. Only 0.16% of non-athletes required medical interventions at the venues and 0.01% required hospital transports. Injury-related medical intervention rates were lower, whereas illness-related rates were comparable to those observed in the total cohort. Hospital transport rates were approximately fourfold lower for injuries and comparable for illnesses, although illness-related estimates need to be interpreted with caution due to sparse event counts. Mild medical conditions were similar, while severe conditions were twofold less frequent. The patterns were consistent across both tournaments and aligned with those reported at previous events, including the Melbourne 2006 Commonwealth Games16 and the 2023 Ryder Cup.17

Difference in medical patterns

Comparisons between groups revealed distinct patterns of medical demands. Athletes had consistently higher rates of both on-site medical interventions and hospital transports than non-athletes across all analyzed outcomes, with the largest between-group differences for injury-related medical interventions, injury-related hospital transports, and severe medical conditions. Although illness-related medical interventions were also more frequent among athletes, illness-related hospital transports remained very infrequent in both groups. The distribution of medical conditions also differed between groups, with injury-related events representing a greater proportion of medical interventions among athletes, whereas non-athletes were characterized predominantly by illness-related and mild medical conditions. Furthermore, although mild medical conditions predominated in both groups, the relative difference between athletes and non-athletes was more pronounced for severe than for mild conditions. Collectively, these findings indicate that medical interventions in athletes were characterized by a substantially greater burden of injury-related and severe medical conditions, whereas illness-related and mild medical conditions predominated among non-athletes.

This overall pattern is consistent with the observed trends in other major international sporting tournaments.12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 28, 29, 30, 31, 32 Figure 6 presents the comparative patterns of medical interventions between athlete and non-athlete groups.

Determinants in hospital transport in athletes

In the present analysis, sport disciplines associated with a higher frequency of hospital transports were identified. Muaythai, American football, BMX freestyle cycling, sumo, and beach handball, each with hospital transport incidences exceeding 10 per 1,000 participant-days, represent contact, high-speed, or team disciplines with an inherently elevated risk of trauma. While several of these disciplines, such as taekwondo, football, handball, rugby, and cycling, align with Olympic disciplines known for elevated injury risk,12, 13, 14, 15, 16, 17 a number of non-Olympic disciplines represented in these tournaments also showed increased hospital transport rates. Boxing, despite accounting for the highest absolute number of hospital transports during EG 2023, exhibited a comparatively lower incidence. Among medical conditions requiring hospital transport, limb and head injuries predominated, consistent with previous reports.12 However, in the analyzed cohort, upper limb injuries predominated over lower limb injuries. Interpreting discipline-specific hospital transport rates requires caution, as several disciplines had few events, resulting in wide CIs and limited precision. Consequently, the observed differences may primarily reflect operational patterns relevant to medical resource planning during multisport tournaments rather than definitive evidence of true discipline-specific risk.

Practical implications

This study provides data-driven insights into medical demands during MSTs. The inclusion of all participant groups enabled a comprehensive assessment of medical needs at the venues.26, 28, 29, 30, 31, 32, 33, 34, 35 Distinct patterns of medical interventions and conditions between groups provide a basis for targeted prevention strategies and more informed medical planning for future tournaments.

The predominance of mild medical conditions and on-site interventions across all groups supports the overall medical safety of these MSTs.30, 31, 32, 33, 34, 35, 36 The higher incidence of illnesses in both groups should be considered in planning for future events. The overall low number of hospital transports guides EMS involvement and referral hospital selection, while underscoring the need for continuous coordination between entities.2, 3, 4, 5, 6, 31, 32, 33, 34, 35, 36, 37 The profile of hospital transports may inform the selection of referral hospitals,33, 36, 37 while the predominance of limb and head injuries and the identification of higher-risk sport disciplines support tailored medical planning.

As tournaments continue to grow in scale and complexity, continuous surveillance of medical data is essential to ensure the provision of required medical services, to monitor trends in medical needs, and to assess the effectiveness of the prevention strategies implemented.12, 34, 35, 36, 37, 38 A structured bottom-up reporting system enables reliable data collection for subsequent analyses. Integration of information from other stakeholders (team physicians, team managers, and event organizers) is required for a more comprehensive assessment of medical demands. Inclusion of the referral hospital data, particularly regarding patient follow-up, would strengthen the evidence for medical analyses.28, 32, 39 For non-athletes, accurate attendance data and demographic profiling would further enhance understanding of medical needs.2, 3, 4, 5, 6, 7, 8, 9, 10, 25, 26, 31, 32, 33

Expanding reporting systems in alignment with IOC surveillance frameworks, while adapting them to include non-athlete populations, would improve comparability and analytical potential across MSTs. Such standardization would ultimately strengthen medical data consistency.12

Limitations of the study

First, the non-athlete population was estimated from ticketing data, which may have overestimated attendance and, consequently, underestimated medical service utilization rates among spectators. Second, athlete-related data did not include reports from team physicians, potentially underrepresenting minor or sport-specific medical conditions managed outside VMTs. Importantly, the on-site medical response captured all conditions requiring hospital transport and included them in the dataset. In addition, the low number of hospital transports, particularly for illness-related conditions, limited the precision of incidence estimates. The dataset did not allow more detailed analyses, such as gender differences. Furthermore, the analysis included complete tournament populations rather than randomly selected samples. Therefore, the findings should be generalized with caution, and the reported CIs and statistical comparisons should be interpreted primarily as measures of variability and tools for comparison between the analyzed tournaments and participant groups. Finally, both tournaments were held in summer conditions, which should be considered when comparing these findings with events conducted in different environmental contexts.

Conclusions

This prospective study demonstrated distinct patterns in the incidence, type, and severity of medical interventions managed by VMTs among athlete and non-athlete populations during 2 international multi-sport tournaments. Athletes experienced substantially higher incidences of medical interventions and hospital transports across all analyzed outcomes, with the greatest between-group differences observed for injury-related and severe medical conditions. Although mild conditions predominated in both groups, illness-related conditions represented a relatively greater proportion of medical interventions among non-athletes, whereas injury-related conditions represented a greater proportion among athletes. Hospital transports were relatively uncommon in both groups but occurred substantially more frequently among athletes, with the vast majority being injury-related.

Comparisons between tournaments indicated generally similar patterns of medical events, although athletes demonstrated higher incidences of most medical outcomes during WG 2017 than during EG 2023. The combined analysis of athlete and non-athlete populations provided a comprehensive assessment of the overall medical workload encountered by VMTs and highlighted the value of standardized surveillance for comparing healthcare demands across participant groups and tournaments. Within the athlete cohort, several sport disciplines, including muaythai, American football, BMX freestyle cycling, sumo, and beach handball, showed higher hospital transport rates; however, the absolute number of events was low. Upper limb, head, and lower limb injuries were the most frequent conditions requiring hospital transport. These findings support evidence-based medical planning by accounting for differences in medical interventions, hospital transport requirements, and medical condition profiles between participant groups and sport disciplines at future international multi-sport tournaments.

Data Availability Statement

The aggregated dataset supporting the findings of this study is available in Zenodo at https://doi.org/10.5281/zenodo.21886930. No individual-level or personally identifiable data are included.

Consent for publication of personal information

Not applicable.

Use of AI and AI–assisted technology

Generative AI (Google Gemini 2.5 Pro, Google DeepMind) was used to improve language and readability; the authors reviewed and take full responsibility for the content.

Tables


Table 1. World Games 2017 disciplines and athletes

Discipline

NOC

Total

Competition days

Africa (n = 12)

Asia (n = 28)

Europe (n = 42)

North America (n = 10)

Oceania (n = 3)

South America (n = 8)

Air sports

1

6

41

10

5

1

64 (1.9%)

4

American football

0

0

140

40

0

0

180 (5.5%)

2

Archery

5

10

60

14

5

2

96 (2.9%)

8

Beach handball

22

20

65

0

20

40

167 (5.1%)

4

Billiards

4

17

30

8

3

2

64 (1.9%)

5

Boules

7

12

61

2

1

12

95 (2.9%)

3

Bowling

0

20

24

12

0

8

64 (1.9%)

4

Canoe polo

0

8

80

8

16

0

112 (3.4%)

3

Dance sports

2

20

100

8

4

12

146 (4.4%)

2

Finswimming

0

17

74

0

0

8

99 (3.0%)

2

Fistball

0

0

31

0

0

29

60 (1.8%)

4

Floorball

0

0

70

14

0

0

84 (2.6%)

4

Flying disc

0

14

14

28

14

14

84 (2.6%)

3

Gymnastics

6

63

188

19

10

9

295 (9.0%)

6

Indoor rowing

4

7

44

3

0

1

59 (1.8%)

2

Ju-jitsu

5

19

93

3

0

7

127 (3.9%)

2

Karate

11

17

48

4

7

9

96 (2.9%)

2

Kickboxing

11

13

59

8

0

5

96 (2.9%)

2

Korfball

0

28

70

0

14

0

112 (3.4%)

5

Lacrosse

0

15

30

30

15

0

90 (2.7%)

4

Life saving

0

20

60

0

20

0

100 (3.0%)

2

Muaythai

3

24

53

4

1

3

88 (2.7%)

2

Orienteering

0

4

64

4

4

4

80 (2.4%)

3

Powerlifting

2

11

41

14

0

12

80 (2.4%)

3

Roller sports

0

14

135

37

3

47

236 (7.2%)

10

Speedway

0

0

18

0

3

0

21 (0.6%)

1

Sport climbing

2

12

44

5

2

1

66 (2.0%)

3

Squash

3

8

40

3

4

3

61 (1.9%)

4

Sumo

6

21

40

10

4

14

95 (2.9%)

2

Tug of war

11

20

164

0

0

0

195 (5.9%)

3

Waterski and wakeboard

0

7

47

15

5

6

80 (2.4%)

4

Total*

105 (3.2%)

447 (13.6%)

2028 (61.6%)

303 (9.2%)

160 (4.9%)

249 (7.6%)

3292 (100%)

11

NOC – National Olympic Committee. *total number of athletes represents the sum across all disciplines; total competition days refer to the overall tournament duration.
Table 2. European Games 2023 disciplines and athletes

Discipline

NOC

Athletes

Competition days

Archery

36

124 (1.9%)

7

Athletics

N/A

1671 (26.2%)

6

Badminton

36

141 (2.2%)

7

3×3 basketball

19

128 (2.0%)

4

Breaking

15

32 (0.5%)

2

Cycling BMX freestyle

19

47 (0.7%)

2

Boxing

43

319 (5.0%)

9

Beach soccer

10

168 (2.6%)

5

Climbing

18

89 (1.4%)

4

Canoe slalom

29

180 (2.8%)

4

Canoe sprint

35

277 (4.3%)

4

Diving

25

126 (2.0%)

7

Fencing

39

464 (7.3%)

6

Beach handball

10

188 (2.9%)

3

Judo

22

213 (3.3%)

1

Kickboxing

22

122 (1.9%)

3

Karate

33

96 (1.5%)

2

Modern pentathlon

25

118 (1.8%)

6

Cycling mountain bike

25

131 (2.1%)

3

Muaythai

23

79 (1.2%)

3

Padel

24

126 (2.0%)

5

Rugby sevens

15

311 (4.9%)

3

Shooting

45

387 (6.1%)

7

Ski jumping

15

93 (1.5%)

5

Artistic swimming

25

170 (2.7%)

5

Teqball

21

68 (1.1%)

4

Taekwondo

44

248 (3.9%)

4

Triathlon

28

112 (1.8%)

3

Table tennis

32

152 (2.4%)

9

Total*

48

6380 (100%)

12

NOC – National Olympic Committee. *total number of athletes represents the sum across all disciplines; total NOCs and competition days refer to the entire tournament.
Table 3. Distribution of medical condition categories among patient medical interventions and hospital transports by group and tournament

Medical condition

Athletes

Non-athletes

medical intervention (%)

hospital transport (%)

medical intervention (%)

hospital transport (%)

WG 2017

EG 2023

WG 2017

EG 2023

WG 2017

EG 2023

WG 2017

EG 2023

Injury-related conditions

Severe injury

42 (18.4)

30 (14.0)

27 (75.0)

24 (57.1)

14 (4.7)

9 (3.2)

7 (43.8)

8 (40.0)

Mild injury

69 (30.3)

58 (27.1)

7 (19.4)

15 (35.7)

76 (25.5)

42 (14.9)

4 (25.0)

4 (20.0)

Total injury

111 (48.7)

88 (41.1)

34 (94.4)

39 (92.9)

90 (30.2)

51 (18.1)

11 (68.8)

12 (60.0)

Illness-related conditions

Severe illness

20 (8.8)

34 (15.9)

2 (5.6)

3 (7.1)

69 (23.2)

36 (12.8)

5 (31.3)

7 (35.0)

Mild illness

97 (42.5)

92 (43.0)

0 (0)

0 (0.0)

139 (46.6)

194 (69.0)

0 (0)

1 (5.0)

Total illness

117 (51.3)

126 (58.9)

2 (5.6)

3 (7.1)

208 (69.8)

230 (81.9)

5 (31.3)

8 (40.0)

Total medical conditions

228 (100)

214 (100)

36 (100)

42 (100)

298 (100)

281 (100)

16 (100)

20 (100)

WG 2017 – World Games 2017; EG 2023 – European Games 2023.
Table 4. Incidence rate per 1,000 participant-days (95% CI) and number per 100 persons (95% CI) for total medical interventions and hospital transports, for athletes and non-athletes, by the WG 2017, the EG 2023, and pooled cohort

Population and outcome

WG 2017

EG 2023

Pooled cohort

Total

Population

173,922

190,965

364,887

Participant-days*

183,417

217,925

401,342

Medical interventions

526

495

1,021

Incidence rate (95% CI)

2.87 (2.63–3.11)

2.27 (2.08–2.47)

2.54 (2.39–2.70)

Number per 100 persons (95% CI)

0.30 (0.28–0.33)

0.26 (0.24–0.28)

0.28 (0.26–0.30)

Hospital transports

52

62

114

Incidence rate (95% CI, PA)

0.28 (0.21–0.36)

0.28 (0.22–0.36)

0.28 (0.24–0.34)

Number per 100 persons (95% CI, PA)

0.03 (0.02–0.04)

0.03 (0.02–0.04)

0.03 (0.03–0.04)

Mild medical conditions

392

406

798

Incidence rate (95% CI)

2.14 (1.93–2.35)

1.86 (1.69–2.05)

1.98 (1.86–2.13)

Number per 100 persons (95% CI)

0.23 (0.20–0.25)

0.21 (0.19–0.23)

0.22 (0.20–0.23)

Severe medical conditions

186

151

337

Incidence rate (95% CI)

1.01 (0.87–1.16)

0.69 (0.59–0.81)

0.84 (0.75–0.93)

Number per 100 persons (95% CI)

0.11 (0.09–0.12)

0.08 (0.07–0.09)

0.09 (0.08–0.10)

Athletes

Population

3,292

6,380

9,672

Participant-days*

12,787

33,340

46,127

Medical interventions

228

214

442

Incidence rate (95% CI)

17.83 (15.66–20.22)

6.42 (5.62–7.31)

9.58 (8.73–10.50)

Number per 100 persons (95% CI)

6.93 (6.10–7.85)

3.35 (2.94–3.82)

4.57 (4.17–5.00)

Hospital transports

36

42

78

Incidence rate (95% CI)

2.82 (2.04–3.81)

1.26 (0.93–1.67)

1.69 (1.36–2.09)

Number per 100 persons (95% CI)

1.09 (0.79–1.51)

0.66 (0.49–0.89)

0.81 (0.65–1.00)

Mild medical conditions

173

165

338

Incidence rate (95% CI)

13.53 (11.66–15.62)

4.95 (4.25–5.73)

7.33 (6.59–8.13)

Number per 100 persons (95% CI)

5.26 (4.55–6.07)

2.59 (2.22–3.00)

3.49 (3.14–3.88)

Severe medical conditions

91

91

182

Incidence rate (95% CI)

7.12 (5.80–8.65)

2.73 (2.22–3.32)

3.95 (3.41–4.54)

Number per 100 persons (95% CI)

2.76 (2.23–3.38)

1.43 (1.16–1.75)

1.88 (1.63–2.17)

Non-athletes

Population

170,630

184,585

355,215

Participant-days*

170,630

184,585

355,215

Medical interventions

298

281

579

Incidence rate (95% CI)

1.75 (1.56–1.95)

1.52 (1.35–1.71)

1.63 (1.50–1.77)

Number per 100 persons (%) (95% CI)

0.17 (0.16–0.20)

0.15 (0.14–0.17)

0.16 (0.15–0.18)

Hospital transports

16

20

36

Incidence rate (95% CI)

0.09 (0.06–0.14)

0.11 (0.07–0.16)

0.10 (0.07–0.14)

Number per 100 persons (%) (95% CI)

0.009 (0.006–0.015)

0.011 (0.007–0.017)

0.01 (0.007–0.014)

Mild medical conditions

219

241

460

Incidence rate (95% CI)

1.28 (1.12–1.46)

1.31 (1.15–1.48)

1.29 (1.18–1.42)

Number per 100 persons (95% CI)

0.13 (0.11–0.15)

0.13 (0.11–0.15)

0.13 (0.12–0.14)

Severe medical conditions

95

60

155

Incidence rate (95% CI)

0.56 (0.46–0.67)

0.33 (0.25–0.41)

0.44 (0.37–0.51)

Number per 100 persons (95% CI)

0.06 (0.05–0.07)

0.03 (0.03–0.04)

0.04 (0.04–0.05)

*Participant-days were calculated as the total number of days of exposure contributed by all participants. WG 2017 – World Games 2017; EG 2023 – European Games 2023; PA – Poisson approximation; 95% CI – 95% confidence interval.
Table 5. Incidence rate per 1,000 participant-days (95% CI) and number per 100 persons (95% CI) for injury-related medical interventions and hospital transports, athletes and non-athletes, by the WG 2017, the EG 2023, and pooled cohort

Population and outcome

WG 2017

EG 2023

Pooled cohort

Total

Population

173,922

190,965

364,887

Participant-days*

183,417

217,925

401,342

Total injuries

246

190

436

Incidence rate (95% CI)

1.34 (1.18–1.51)

0.87 (0.75–1.00)

1.09 (0.99–1.19)

Number per 100 persons (95% CI)

0.14 (0.12–0.16)

0.10 (0.09–0.11)

0.12 (0.11–0.13)

Injury-related medical interventions

201

139

340

Incidence rate (95% CI)

1.10 (0.95–1.25)

0.64 (0.54–0.75)

0.85 (0.76–0.94)

Number per 100 persons (95% CI)

0.12 (0.10–0.13)

0.07 (0.06–0.09)

0.09 (0.08–0.10)

Injury-related hospital transports

45

51

96

Incidence rate (95% CI)

0.25 (0.18–0.32)

0.23 (0.18–0.30)

0.24 (0.20–0.29)

Number per 100 persons (95% CI)

0.03 (0.02–0.03)

0.03 (0.02–0.03)

0.03 (0.02–0.03)

Athletes

Population

3,292

6,380

9,672

Participant-days*

12,787

33,340

46,127

Injury-related medical interventions

111

88

199

Incidence rate (95% CI)

8.68 (7.21–10.37)

2.64 (2.14–3.22)

4.31 (3.76–4.93)

Number per 100 persons (95% CI)

3.37 (2.81–4.04)

1.38 (1.12–1.70)

2.06 (1.79–2.36)

Injury-related hospital transports

34

39

73

Incidence rate (95% CI)

2.66 (1.91–3.62)

1.17 (0.86–1.56)

1.58 (1.26–1.97)

Number per 100 persons (95% CI)

1.03 (0.74–1.44)

0.61 (0.45–0.83)

0.75 (0.60–0.95)

Non-athletes

Population

170,630

184,585

355,215

Participant-days*

170,630

184,585

355,215

Injury-related medical interventions

90

51

141

Incidence rate (95% CI)

0.53 (0.43–0.64)

0.28 (0.21–0.36)

0.40 (0.34–0.47)

Number per 100 persons (95% CI)

0.05 (0.04–0.07)

0.03 (0.02–0.04)

0.04 (0.03–0.05)

Injury-related hospital transports

11

12

23

Incidence rate (95% CI)

0.06 (0.04–0.11)

0.07 (0.04–0.10)

0.06 (0.04–0.09)

Number per 100 persons (95% CI)

0.006 (0.004–0.012)

0.0065 (0.0037–0.0114)

0.006 (0.004–0.010)

*Participant-days were calculated as the total number of days of exposure contributed by all participants. WG 2017 – World Games 2017; EG 2023 – European Games 2023; 95% CI – 95% confidence interval.
Table 6. Incidence rate per 1,000 participant-days (95% CI) and number per 100 persons (95% CI) for illness-related medical interventions and hospital transports, athletes and non-athletes, by the WGs 2017, the EG 2023, and pooled cohort

Population and outcome

WG 2017

EG 2023

Pooled cohort

Total

Population

173,922

190,965

364,887

Participant-days*

183,417

217,925

401,342

Total illnesses

332

367

699

Incidence rate (95% CI)

1.81(1.63–2.01)

1.68 (1.52–1.86)

1.74 (1.62–1.87)

Number per 100 persons (95% CI)

0.19 (0.17–0.21)

0.19 (0.17–0.21)

0.19 (0.18–0.21)

Illness-related medical interventions

325

356

681

Incidence rate (95% CI)

1.77 (1.59–1.97)

1.63 (1.47–1.80)

1.70 (1.57–1.83)

Number per 100 persons (95% CI)

0.18 (0.17–0.21)

0.19 (0.16–0.20)

0.19 (0.17–0.20)

Illness-related hospital transports

7

11

18

Incidence rate (95% CI, PA)

0.04 (0.02–0.07)

0.05 (0.03–0.08)

0.04 (0.03–0.07)

Number per 100 persons (95% CI, PA)

0.004 (0.002–0.008)

0.006 (0.003–0.010)

0.005 (0.003–0.008)

Athletes

Population

3,292

6,380

9,672

Participant-days*

12,787

33,340

46,127

Illness-related medical interventions

117

126

243

Incidence rate (95% CI)

9.15 (7.64–10.88)

3.78 (3.17–4.46)

5.27 (4.65–5.95)

Number per 100 persons (95% CI)

3.55 (2.97–4.24)

1.97 (1.64–2.34)

2.51 (2.22–2.84)

Illness-related hospital transports

2

3

5

Incidence rate (95% CI, PA)

0.16 (0.05–0.43)

0.09 (0.03–0.22)

0.11 (0.05–0.22)

Number per 100 persons (95% CI, PA)

0.061 (0.017–0.221)

0.05 (0.016–0.14)

0.05 (0.02–0.12)

Non-athletes

Population

170,630

184,585

355,215

Participant-days*

170,630

184,585

355,215

Illness-related medical interventions

208

230

438

Incidence rate (95% CI)

1.22 (1.06–1.39)

1.25 (1.09–1.41)

1.23 (1.12–1.35)

Number per 100 persons (95% CI)

0.12 (0.11–0.14)

0.12 (0.10–0.14)

0.12 (0.11–0.14)

Illness-related hospital transports

5

8

13

Incidence rate (95% CI, PA)

0.03 (0.01–0.06)

0.04 (0.02–0.07)

0.04 (0.02–0.06)

Number per 100 persons (95% CI, PA)

0.003 (0.001–0.007)

0.004 (0.001–0.008)

0.004 (0.002–0.006)

*Participant-days were calculated as the total number of days of exposure contributed by all participants. WG 2017 – World Games 2017; EG 2023 – European Games 2023; PA – Poisson approximation; 95% CI – 95% confidence interval.
Table 7. Comparative analysis of medical event rates in athletes and non-athletes during the WG 2017, the EG 2023, and between tournaments using Poisson IRRs and 95% CIs

Outcome

Athletes vs non-athletes (pooled cohort) IRR (95% CI)

WG 2017 vs EG 2023 (total population) IRR (95% CI)

WG 2017 vs EG 2023 IRR among athletes (95% CI)

WG 2017 vs EG 2023 IRR among non-athletes (95% CI)

Total medical interventions

5.88 (5.19–6.65)

1.26 (1.12–1.43)

2.78 (2.31–3.35)

1.15 (0.97–1.35)

Total hospital transports

16.69 (11.24–24.77)

1.00 (0.69–1.44)

2.23 (1.43–3.49)

0.87 (0.45–1.67)

Mild medical conditions

5.66 (4.92–6.51)

1.15 (1.00–1.32)

2.73 (2.21–3.38)

0.98 (0.82–1.18)

Severe medical conditions

9.04 (7.30–11.20)

1.46 (1.18–1.81)

2.61 (1.95–3.49)

1.71 (1.24–2.37)

Injury-related medical interventions

10.87 (8.76–13.49)

1.72 (1.38–2.13)

3.29 (2.49–4.35)

1.91 (1.35–2.69)

Injury-related hospital transports

24.44 (15.30–39.05)

1.05 (0.70–1.57)

2.27 (1.44–3.60)

0.99 (0.44–2.25)

Illness-related medical interventions

4.27 (3.65–5.00)

1.08 (0.93–1.26)

2.42 (1.88–3.11)

0.98 (0.81–1.18)

Illness-related hospital transports*

2.96 (1.06–8.31)

0.76 (0.29–1.95)

1.74 (0.29–10.40)

0.68 (0.22–2.07)

*Interpret with caution because of sparse event counts. IRR – incidence rate ratio; 95% CI – 95% confidence interval; WG 2017 – World Games 2017; EG 2023 – European Games 2023.

Figures


Fig. 1. Example of the daily medical report from the World Games 2017
Fig. 2. Hospital transport incidence rate in athlete group by disciplines during the World Games 2017
Fig. 3. Hospital transport incidence rate in athlete group by sport disciplines during the European Games 2023
Fig. 4. Medical conditions related to hospital transport incidence rate in athlete group during the World Games 2017
Fig. 5. Medical conditions related to hospital transport incidence rate in the athlete group during the European Games 2023
Fig. 6. The comparative patterns of medical demands between pooled athlete and non-athlete groups

References (39)

  1. World Health Organization (WHO). Mass Gathering Practical Guide for Simulation Exercises and After-Action Reviews. Geneva, Switzerland: World Health Organization (WHO); 2025. ISBN:978-92-4-010484-6.
  2. Suy K, Gijsenbergh F, Baute L. Emergency medical assistance during a mass gathering. Eur J Emerg Med. 1999;6(3):249–254. doi:10.1097/00063110-199909000-00014
  3. Schwartz B, Nafziger S, Milsten A, Luk J, Yancey A. Mass gathering medical care: Resource document for the National Association of EMS Physicians Position Statement. Prehosp Emerg Care. 2015;19(4):559–568. PMID:26270473.
  4. Hendricks S, Rotunno A, Gordon L, et al. Mass-gatherings in sport: Medicine, leadership and mentorship. Br J Sports Med. 2024;58(10):528–530. doi:10.1136/bjsports-2024-108377
  5. Mirra L. Medical and medical support staffing at mass gathering events. In: Brady WJ, Sochor MR, Pepe PE, Maino Ii JC, Dyer KS, eds. Mass Gathering Medicine: A Guide to the Medical Management of Large Events. Cambridge, UK–New York, USA: Cambridge University Press; 2024:57–73. doi:10.1017/9781009105156
  6. Zeitz KM, Zeitz CJ, Arbon P. Forecasting medical work at mass-gathering events: Predictive model versus retrospective review. Prehosp Disaster Med. 2005;20(3):164–168. doi:10.1017/S1049023X00002399
  7. Margolis AM, Leung AK, Friedman MS, McMullen SP, Guyette FX, Woltman N. Position Statement: Mass Gathering Medical Care. Prehosp Emerg Care. 2021;25(4):593–595. doi:10.1080/10903127.2021.1903632
  8. Milsten AM, Maguire BJ, Bissell RA, Seaman KG. Mass-gathering medical care: A review of the literature. Prehosp Disaster Med. 2002;17(3):151–162. doi:10.1017/S1049023X00000388
  9. Koski A, Kouvonen A, Sumanen H. Preparedness for mass gatherings: Factors to consider according to the rescue authorities. Int J Environ Res Public Health. 2020;17(4):1361. doi:10.3390/ijerph17041361
  10. Locoh-Donou S, Yan G, Berry T, et al. Mass gathering medicine: Event factors predicting patient presentation rates. Intern Emerg Med. 2016;11(5):745–752. doi:10.1007/s11739-015-1387-1
  11. Sultana N, Crilly J, Ware RS, Ranse J. Factors influencing patient presentation and transfer to hospital rates during mass-gathering stadium events: A scoping review. Prehosp Disaster Med. 2025;40(2):101–113. doi:10.1017/S1049023X25000287
  12. Torvaldsson K, Fagher K, Derman W, et al. Injury and illness epidemiology in elite athletes during the Olympic, Youth Olympic and Paralympic Games: A systematic review and meta-analysis. Br J Sports Med. 2025;59(18):1302–1314. doi:10.1136/bjsports-2025-109980
  13. Junge A, Engebretsen L, Mountjoy ML, et al. Sports injuries during the Summer Olympic Games 2008. Am J Sports Med. 2009;37(11):2165–2172. doi:10.1177/0363546509339357
  14. Engebretsen L, Soligard T, Steffen K, et al. Sports injuries and illnesses during the London Summer Olympic Games 2012. Br J Sports Med. 2013;47(7):407–414. doi:10.1136/bjsports-2013-092380
  15. Soligard T, Steffen K, Palmer D, et al. Sports injury and illness incidence in the Rio de Janeiro 2016 Olympic Summer Games: A prospective study of 11274 athletes from 207 countries. Br J Sports Med. 2017;51(17):1265–1271. doi:10.1136/bjsports-2017-097956
  16. Soligard T, Palmer D, Steffen K, et al. New sports, COVID-19 and the heat: Sports injuries and illnesses in the Tokyo 2020 Summer Olympics. Br J Sports Med. 2023;57(1):46–54. doi:10.1136/bjsports-2022-106155
  17. Steffen K, Soligard T, Mountjoy M, et al. How do the new Olympic sports compare with the traditional Olympic sports? Injury and illness at the 2018 Youth Olympic Summer Games in Buenos Aires, Argentina. Br J Sports Med. 2020;54(3):168–175. doi:10.1136/bjsports-2019-101040
  18. Li Z, Li S, Liu Z, et al. Sports injury and illness incidence at the 2021 Summer Universiade: A retrospective study of 6,500 athletes from 113 countries/regions. Front Public Health. 2025;13:1532849. doi:10.3389/fpubh.2025.1532849
  19. Dutch MJ, Senini LM, Taylor DJ. Mass gathering medicine: The Melbourne 2006 Commonwealth Games experience. Emerg Med Australas. 2008;20(3):228–233. doi:10.1111/j.1742-6723.2008.01085.x
  20. Mercalli C, Ghio FE, Bonizzato S, et al. Providing medical care at mass gathering sporting events: The 2023 Ryder Cup experience. BMC Emerg Med. 2025;25(1):151. doi:10.1186/s12873-025-01316-7
  21. McCartney G, Thomas S, Thomson H, et al. The health and socioeconomic impacts of major multi-sport events: Systematic review (1978–2008). BMJ. 2010;340:c2369. doi:10.1136/bmj.c2369
  22. Hiltunen T, Kuisma M, Määttä T, et al. Prehospital emergency care and medical preparedness for the 2005 World Championship Games in Athletics in Helsinki. Prehosp Disaster Med. 2007;22(4):304–311. doi:10.1017/S1049023X0000491X
  23. Moreno Millán E, Bonilla F, Alonso JM, Casado F. Medical care at the VIIth International Amateur Athletics Federation World Championships in Athletics ’Sevilla 99’. Eur J Emerg Med. 2004;11(1):39–43. doi:10.1097/00063110-200402000-00008
  24. Centers for Disease Control and Prevention (CDC). Prevention and management of heat-related illness among spectators and staff during the Olympic Games (Atlanta, July 6–23, 1996). MMWR Morb Mortal Wkly Rep. 1996;45(29):631–633. PMID:8965791.
  25. Çalışkan C, Kuday AD, Özcan T, Dağ N, Kınık K. Quantitative metrics in mass-gathering studies: A comprehensive systematic review. Prehosp Disaster Med. 2024;39(2):195–205. doi:10.1017/S1049023X2400027X
  26. Ranse J, Hutton A. Minimum dataset for mass-gathering health research and evaluation: A discussion paper. Prehosp Disaster Med. 2012;27(6):543–550. doi:10.1017/S1049023X12001288
  27. Bahr R, Clarsen B, Derman W, et al. International Olympic Committee consensus statement: Methods for recording and reporting of epidemiological data on injury and illness in sport 2020 (including STROBE Extension for Sport Injury and Illness Surveillance (STROBE-SIIS)). Br J Sports Med. 2020;54(7):372–389. doi:10.1136/bjsports-2019-101969
  28. Simon E, Trager JD, Wilson B. Patient care at mass gathering events: Basic, advanced, and critical care. In: Brady W, Sochor MR, Pepe PE, Maino JC, Dyer KS, eds. Mass Gathering Medicine: A Guide to the Medical Management of Large Events. Cambridge, UK–New York, USA: Cambridge University Press; 2024:6–20. doi:10.1017/9781009105156
  29. World Health Organization (WHO). Public Health for Mass Gatherings: Key Considerations. Geneva, Switzerland: World Health Organization (WHO); 2015. ISBN:978-92-4-156493-9.
  30. Peters GA, Goralnick E. Occurrence of the mass casualty incident at a mass gathering event. In: Brady W, Sochor MR, Pepe PE, Maino JC, Dyer KS, eds. Mass Gathering Medicine: A Guide to the Medical Management of Large Events. Cambridge, UK–New York, USA: Cambridge Medicine. Cambridge University Press; 2024:320–341. doix:10.1017/9781009105156
  31. Locoh-Donou S, Guofen Y, Welcher M, Berry T, O’Connor RE, Brady WJ. Mass-gathering medicine: A descriptive analysis of a range of mass-gathering event types. Am J Emerg Med. 2013;31(5):843–846. doi:10.1016/j.ajem.2013.01.016
  32. Ranse J, Hutton A, Keene T, et al. Health service impact from mass gatherings: A systematic literature review. Prehosp Disaster Med. 2017;32(1):71–77. doi:10.1017/S1049023X16001199
  33. Stiers M, Van Asbroeck PJ, Hoogmartens O, Guldentops J, Sabbe M. Redefining the role of emergency medicine in mass gatherings. Eur J Emerg Med. 2024;31(3):171–172. doi:10.1097/MEJ.0000000000001131
  34. Hartman N, Williamson A, Sojka B, et al. Predicting resource use at mass gatherings using a simplified stratification scoring model. Am J Emerg Med. 2009;27(3):337–343. doi:10.1016/j.ajem.2008.03.042
  35. Arbon P, Bridgewater FHG, Smith C. Mass gathering medicine: A predictive model for patient presentation and transport rates. Prehosp Disaster Med. 2001;16(3):150–158. doi:10.1017/S1049023X00025905
  36. Lipska E, Mikrut M, Pawlak A. On-site medical interventions for spectators at venues during major international sporting tournaments: A prospective comparative study of four single-sport and multi-sport tournaments. Front Public Health. 2026;14:1812763. doi:10.3389/fpubh.2026.1812763
  37. Lipska E, Kavouras A. Impact of major international sport tournaments on the local healthcare system in Poland: A retrospective analysis. Med Res J. 2026;11:VM/OJS/J/110724, e04426017. doi:10.5603/mrj.110724
  38. Lund A, Turris SA, Amiri N, Lewis K, Carson M. Mass-gathering medicine: Creation of an online event and patient registry. Prehosp Disaster Med. 2012;27(6):601–611. doi:10.1017/S1049023X12001367
  39. Lipska E, Szafran B. Cardiac arrest during stadium test event: Case report. Emerg Med Serv. 2025;12(1):42–46. doi:10.36740/EmeMS202501107